Silvia Mancuso | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study.	FRONTIERS IN IMMUNOLOGY	2025
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations	JOURNAL OF CLINICAL MEDICINE	2024
Antibody profiles in the mosaic of "seronegative" APS syndrome	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2024
Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients. results from a cross-sectional analysis.	LUPUS	2024
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors.	REUMATISMO	2024
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2023
Should we vaccinate during an active rheumatic disease?	AUTOIMMUNITY REVIEWS	2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.	SCIENTIFIC REPORTS	2023
Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome. a new tool for diagnosis of "seronegative" patients	RHEUMATOLOGY	2022
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2022
Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2022
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome	FRONTIERS IN IMMUNOLOGY	2022
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2022
Anti-vimentin/cardiolipin IgA in the antiphospholipid syndrome: a new tool for “seronegative” diagnosis	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2021
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2021
Comprehensive disease control in systemic lupus erythematosus	SEMINARS IN ARTHRITIS AND RHEUMATISM	2021
Comment on. real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway	RHEUMATOLOGY	2021
“Non-criteria antiphospholipid antibodies”: bridging the gap between seropositive and seronegative Antiphospholipid Syndrome	RHEUMATOLOGY	2021
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2021
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab. a case report	RHEUMATOLOGY	2021